Inclusion and Exclusion Criteria. Neither OPKO nor any of its Representatives will provide a waiver for any exclusion or inclusion criteria related to a Trial as specified in the Development Plan. Any changes to the exclusion or inclusion criteria will be subject to an amendment to the Development Plan to be approved by the JDC pursuant to the terms of this Agreement.
Inclusion and Exclusion Criteria. All patients with chronic angioedema, i.e. recurrent swelling attacks for longer than 6 weeks, can be enrolled/recorded in the registry, if a written, dated and signed informed consent is available. The data for CARE are collected from the real-life management situation in clinical practice (observational approach). As children and adolescents (minors) can also be affected by chronic angioedema, it makes sense to not exclude these patient groups from participation. Before including patient data into the registry, a dated and signed written informed consent by the patient or the parent / legal guardian (i.e. the legal authorized representative - LAR) must be available.
Inclusion and Exclusion Criteria. CRO will not waive any exclusion or inclusion criteria specified in the Protocol, and shall require that no Clinical Investigator or Site do so.
Inclusion and Exclusion Criteria. This review was conducted in line with the Preferred Reporting Items for Systematic reviews and Meta Analyses (PRISMA) standard (Moher et al. 2009) where applicable. Risk bias was not considered in this review. The initial search carried out in 2018 used Medline, a bibliographic database of life sciences and biomedical information from academic journals covering medicine, nursing, pharmacy, dentistry, veterinary medicine, and health care. Medline provides an advanced search capacity covering over 23 million article references. It also uses Medical Subject Heading (MeSH) terms and spans over 50 years. This initial search extracted articles published within the preceding five years (2013-2018) in order to cover the most up-to-date evidence in the area. The following inclusion criteria were applied in the search:
Inclusion and Exclusion Criteria. 3.5.1 Opportunistic screening of asymptomatic young people for chlamydia and gonorrhoea (Component A) (See separate specification – ‘Participation in the Ruclear chlamydia and gonorrhoea screening programme (Pharmacies) Component A’)
Inclusion and Exclusion Criteria. 3.5.1 Opportunistic chlamydia and gonorrhoea screening for asymptomatic young people Inclusion criteria The Contractor is required to offer Ruclear* screening kits to: Asymptomatic residents of Greater Manchester aged 16-24. Exclusion criteria The Contractor is required to exclude: Symptomatic young people Young people aged under-16 Adults aged 25 and over Young people not resident in Greater Manchester The Contractor should refer excluded clients, as appropriate, to other services including: Symptomatic young people should be referred / signposted to STI testing services. Young people aged under-16 should be referred / signposted to STI testing services. Adults aged 25 and over should be signposted to STI testing services Young people not resident in Greater Manchester should be signposted to STI testing services in their own area of residence.
Inclusion and Exclusion Criteria. After removing duplicates, articles underwent a review for eligibility based on the following criteria: (i) population—patients with HCC risk factors defined by LI-RADS1; (ii) index test—multiphasic CT or MRI; (iii) comparator—no specific requirements; (iv) outcomes—inter-reader agreement of LR-M imaging features, including five targetoid features (rim APHE, peripheral washout, DCE, targetoid restriction, and targetoid TP/HBP appearance) and three non-targetoid features (infiltrative appearance, marked diffusion restriction, and necrosis or severe ischemia); and (v) study design—any type of study, including observational studies and clinical trials. The exclusion criteria were as follows: (i) animal studies, case reports, review articles, editorials, abstracts/conference proceedings, meta-analyses, and systematic reviews; (ii) studies outside the scope of interest of this investigation; (iii) studies lacking sufficient data for extracting inter-reader agreement (e.g., absence of standard variance or 95% confidence intervals [CIs]); and (iv) studies with overlapping patient cohorts. The initial screening involved titles and abstracts, followed by full-text reviews of the selected potentially eligible abstracts. Data extraction Each study’s data were extracted using a standardized form prepared using Microsoft Excel. The extracted information included: (i) study characteristics such as first author, year of publication, and study design (prospective vs. retrospective); (ii) subject characteristics, including sample size, sex, age, underlying liver disease, number of hepatic observations, percentages of HCC and/or other malignancy among observations, and observation size; (iii) type of imaging modality (CT vs. MRI), MRI scanner field strength, and contrast agent used;
Inclusion and Exclusion Criteria. All patients have a baseline stress perfusion CMR scan and further management will depend on whether they have been randomised to the MR-INFORMED or the FFR-INFORMED arm of the trial. In addition, all patients receive optimal medical therapy.
Inclusion and Exclusion Criteria. Criteria Included Excluded Rationale Sampling Method Population-based Clinic-based, convenience- based etc. The study aims to understand population- level health outcomes Analysis At least bivariate Included as a minimum in order to capture the various ways that empowerment and vaccinations are measured and operationalized Date January 1, 1970- September 1, 2013 Anything below or above range This date range covers the period during which WHO established the expanded program on immunization (in 1974). Geographic (Based on World Bank Definitions) Low Income; Lower-Middle Income; Upper-middle Income High-income Focus of this review is on geographic locations that bear a the high burden of vaccine preventable diseases [2]. Outcome Variable Complete vaccination or at least one of the recommended vaccines (BCG, Hepatitis B, Polio, DTP, Haemophilus Influenza Type B, Pneumococcal, Rotavirus, measles, and Rubella) Influenza and/or HPV This review followed the WHO guidelines for recommended vaccines for children under five. Exposure Variable Decision-making and/or Freedom of Movement The term empowerment serves as the umbrella term under which agency is conceptualized. We defined women’s decision-making and freedom of movement as domains of agency as expressed in the Kabeer Framework (Figure 1) [19].
Inclusion and Exclusion Criteria. Eligible participants will be recruited using electronic medical records from Northwestern Medicine Enterprise Data Warehouse (NMEDW) using the below inclusion/exclusion criteria for search criteria. No special populations will be targeted for the enrollment in this study. Additional patient referrals will be made by the physicians who are participating as investigators on this study. The referring physicians of patients to the study will make an assessment if a potential study subject can provide informed consent and will not refer patients unlikely to understand what is being asked of them. All potential subjects will be evaluated by research staff to match them to the inclusion and exclusion criteria that has been established.
